Connect
MJA
MJA

Summary of the Australasian Society for Infectious Diseases and the Thoracic Society of Australia and New Zealand guidelines: treatment and prevention of H1N1 influenza 09  (human swine influenza) with antiviral agents

Allen C Cheng, Dominic E Dwyer, A Thomas C Kotsimbos, Mike Starr, Tony M Korman, Jim P Buttery, Christine R Jenkins, Vicki L Krause and Paul D R Johnson
Med J Aust 2009; 191 (3): 142-145.
Published online: 3 August 2009

The complete, up-to-date guidelines can be found at: http://www.mja.com.au/ public/rop/cheng/che10661_fm.html

  • Allen C Cheng1,2
  • Dominic E Dwyer3
  • A Thomas C Kotsimbos1
  • Mike Starr4
  • Tony M Korman5
  • Jim P Buttery4,5
  • Christine R Jenkins6
  • Vicki L Krause7
  • Paul D R Johnson8

  • 1 Alfred Hospital, Melbourne, VIC.
  • 2 Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC.
  • 3 Centre for Infectious Diseases and Microbiology Laboratory Services, and Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, NSW.
  • 4 Royal Children’s Hospital, Melbourne, VIC.
  • 5 Department of Infectious Diseases, Monash Medical Centre, Melbourne, VIC.
  • 6 Concord Hospital, Sydney, NSW.
  • 7 Centre for Disease Control, Northern Territory Department of Health and Families, Darwin, NT.
  • 8 Infectious Diseases Department, Austin Health, Melbourne, VIC.


Acknowledgements: 

We thank the other members of the Guidelines Committee of the ASID (Bart Currie, Monica Slavin, Joe Torresi, Alison Kesson, John Ferguson, Ronan Murray) and the Swine Influenza Task Force of the TSANZ (Grant Waterer, Graeme Maguire, Louis Irving, Mark Holmes, Richard Wood-Baker, Simon Bowler). We also acknowledge the following for their comments on an earlier draft of the guidelines: Craig Dalton, David Looke, David Andresen, Tom Gottlieb, Craig Boutlis, Ian Gust, John Mills, Deb Friedman, Mark Veitch, Joshua Wolf and James McCaw.

Competing interests:

Dominic Dwyer has undertaken clinical trials with anti-influenza drugs and new laboratory assays for Roche, GlaxoSmithKline and other companies. Jim Buttery has served as an investigator or on data-safety monitoring committees for influenza vaccine trials for Wyeth Vaccines and CSL. Paul Johnson has worked as a consultant for Biota, but not regarding antiviral drugs.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.